4G Clinical Launches Direct-to-Patient Platform

Article

Applied Clinical Trials

4G Clinical has announced the launch of a Direct-to-Patient (DtP) clinical trial platform, offering sponsors the flexibility to ship drug from the sites to the patient's home. In the midst of the COVID-19 pandemic, clinical trial models are shifting towards DtP to address patient safety & access to trial sites, site capacity challenges, and supply chain disruption.  

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.